2016-07-14 12:40:56

Resolution No. 713/2016
of the Management Board of the Warsaw Stock Exchange
dated 12 July 2016

concerning a special designation of financial instruments of
the 'BIOMED-LUBLIN' WYTWÓRNIA SUROWIC I SZCZEPIONEK S.A.
on the GPW Main List and in the alternative trading system on Catalyst

§ 1

Pursuant to § 2 and § 3.2 of the Division 7 of the Detailed Exchange Trading Rules in UTP and § 149 and § 150.2 of the Exhibit No. 2 to the Alternative Trading System Rules, Warsaw Stock Exchange Management Board resolves that information provided in the Ceduła Giełdy Warszawskiej and on the Warsaw Stock Exchange website concerning listing of financial instruments of the company 'BIOMED-LUBLIN' WYTWÓRNIA SUROWIC I SZCZEPIONEK S.A. shall be specially designated with an ordinal number reference meaning
-'the court issued a decision approving an arrangement'.

§ 2

Resolution No. 100/2016 of the Exchange Management Board dated 3 February 2016 concerning a special designation of financial instruments of the 'BIOMED-LUBLIN' WYTWÓRNIA SUROWIC I SZCZEPIONEK S.A. on the GPW Main List and in the alternative trading system on Catalyst.

§ 3

This Resolution shall take effect on the date of adoption.

WSE - Warsaw Stock Exchange SA published this content on 14 July 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 14 July 2016 10:53:05 UTC.

Original documenthttps://www.gpw.pl/komunikaty_en/?ph_tresc_glowna_start=show&ph_tresc_glowna_cmn_id=58538

Public permalinkhttp://www.publicnow.com/view/C055DD258B21D5A7C0BDD2F66F97AB808C5D8A41